A critical breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various forms of cancer, resulting https://zbookmarkhub.com/story22117340/nanobodies-revive-p53-a-potential-pathway-for-cancer-treatment